Article Text

Download PDFPDF
Original research
Urban metabolic and airway immune profiles increase the risk of infections in early childhood
  1. Nicklas Brustad1,
  2. Jonathan Thorsen1,
  3. Casper Emil Tingskov Pedersen1,
  4. Mina Ali2,
  5. Julie Kyvsgaard1,3,
  6. Sarah Brandt1,
  7. Jenni Lehtimäki4,
  8. Nicole Prince5,
  9. Nilofar V Følsgaard2,
  10. Jessica Lasky-Su6,
  11. Jakob Stokholm1,
  12. Klaus Bønnelykke7,
  13. Bo Chawes2
  1. 1 Copenhagen Prospective Studies on Asthma in Childhood, Gentofte, Denmark
  2. 2 University of Copenhagen, Kobenhavn, Denmark
  3. 3 Department of Pediatrics, Slagelse Sygehus, Næstved, Denmark
  4. 4 Finnish Environment Institute, Helsinki, Finland
  5. 5 Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA
  6. 6 Brigham and Women's Hospital Channing Division of Network Medicine, Boston, Massachusetts, USA
  7. 7 Copenhagen University Hospital, Gentofte, Copenhagen Prospective Studies on Asthma in Childhood, Copenhagen, Denmark
  1. Correspondence to Prof Bo Chawes; chawes{at}copsac.com

Abstract

Background Infections in childhood remain a leading global cause of child mortality and environmental exposures seem crucial. We investigated whether urbanicity at birth was associated with the risk of infections and explored underlying mechanisms.

Methods Children (n=633) from the COPSAC2010 mother–child cohort were monitored daily with symptom diaries of infection episodes during the first 3 years and prospectively diagnosed with asthma until age 6 years. Rural and urban environments were based on the CORINE land cover database. Child airway immune profile was measured at age 4 weeks. Maternal and child metabolomics profiling were assessed at pregnancy week 24 and at birth, respectively.

Results We observed a mean (SD) total number of infections of 16.3 (8.4) consisting mainly of upper respiratory infections until age 3 years. Urban versus rural living increased infection risk (17.1 (8.7) vs 15.2 (7.9), adjusted incidence rate ratio; 1.15 (1.05–1.26), p=0.002) and altered the child airway immune profile, which increased infection risk (principal component 1 (PC1): 1.03 (1.00–1.06), p=0.038 and PC2: 1.04 (1.01–1.07), p=0.022). Urban living also altered the maternal and child metabolomic profiles, which also increased infection risk. The association between urbanicity and infection risk was partly mediated through the maternal metabolomic and child airway immune profiles. Finally, urbanicity increased the risk of asthma by age 6 years, which was mediated through early infection load (pACME<0.001).

Conclusion This study suggests urbanicity as an independent risk factor for early infections partly explained by changes in the early metabolic and immunological development with implications for later risk of asthma.

  • Child
  • Respiratory Infection
  • Asthma

Data availability statement

Data are available upon reasonable request. Data will be available on request by email to nicklas.brustad@dbac.dk.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Data availability statement

Data are available upon reasonable request. Data will be available on request by email to nicklas.brustad@dbac.dk.

View Full Text

Footnotes

  • Contributors NB has written the first draft of the manuscript. NB and JT have performed the statistical analyses. The guarantor of the study is BLKC, from conception and design to conduct of the study and acquisition of data, data analysis, and interpretation of data. NB, JT, CETP, MA, JK, SB, JL, NP, NVF, JL-S, JS, KB and BLKC have provided important intellectual input and contributed to the interpretation of the analysis and reviewed the final version.

  • Funding We express our deepest gratitude to the children and families of the COPSAC2010 cohort study for all their support and commitment. We acknowledge and appreciate the unique efforts of the COPSAC research team.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.